EGR1 and Cognitive impairment: Lower initial levels of EGR1 following early life adversity could thus result in a lower capacity to counteract, or ‘deal with’, Aβ neurotoxicity and an earlier display of cognitive impairment, whereas higher baseline EGR1 expression following positive early life experiences would allow the brain to counteract Aβ neurotoxicity for a longer period of time.